Predictive Effect of Model for End-stage Liver Disease Score Combined with Procalcitoninon Acute Kidney Injury in Hepatitis B Virus-related Acute-on-chronic Liver Failure
التفاصيل البيبلوغرافية
العنوان:
Predictive Effect of Model for End-stage Liver Disease Score Combined with Procalcitoninon Acute Kidney Injury in Hepatitis B Virus-related Acute-on-chronic Liver Failure
Objective To investigate the predictive value of the model for end-stage liver disease(MELD) score combined with procalcitonin(PCT) for acute kidney injury in patients with hepatitis B virus-associated acute-on-chronic liver failure(HBV-ACLF). Methods A retrospective analysis of 216 HBV-ACLF patients hospitalized in the First Affiliated Hospital of Harbin Medical University from January 2019 to December 2022 was performed.According to whether acute kidney injury occurred during hospitalization,they were divided into an acute kidney injury group(51 cases) and a non acute kidney injury group(165 cases).The clinical data of the patients was collected,A multivariate logistic regression model was used to screen the influencing factors of acute kidney injury in HBV-ACLF patients,and the ROC curve was used to evaluate the predictive value of MELD score combined with PCT for the occurrence of acute kidney injury in HBV-ACLF patients. Results Univariate analysis showed that there were significant differences in age,albumin, prothrombin time,PCT,acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ),and MELD scores between the two groups(P
Full Text Finder